{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:44:31Z","timestamp":1788410671433,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["Age-It: \"Ageing Well in an Ageing Society\""],"award-info":[{"award-number":["Age-It: \"Ageing Well in an Ageing Society\""]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2021-12374238"],"award-info":[{"award-number":["RF-2021-12374238"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00415-025-13190-1","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T05:04:02Z","timestamp":1749531842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Osteopontin levels in the serum reflect anatomical disease progression in patients with amyotrophic lateral sclerosis"],"prefix":"10.1007","volume":"272","author":[{"given":"Tommaso","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teuta","family":"Domi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paride","family":"Schito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri Matteo","family":"Falzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilo","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo G.","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Agosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5485-0479","authenticated-orcid":false,"given":"Massimo","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Quattrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"13190_CR1","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A et al (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3:17071. https:\/\/doi.org\/10.1038\/nrdp.2017.71","journal-title":"Nat Rev Dis Primers"},{"key":"13190_CR2","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.tins.2021.04.008","volume":"44","author":"ACM Van Harten","year":"2021","unstructured":"Van Harten ACM, Phatnani H, Przedborski S (2021) Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis. Trends Neurosci 44:658\u2013668. https:\/\/doi.org\/10.1016\/j.tins.2021.04.008","journal-title":"Trends Neurosci"},{"key":"13190_CR3","doi-asserted-by":"publisher","first-page":"767041","DOI":"10.3389\/fnmol.2021.767041","volume":"14","author":"E Liu","year":"2021","unstructured":"Liu E, Karpf L, Bohl D (2021) Neuroinflammation in amyotrophic lateral sclerosis and frontotemporal dementia and the interest of induced pluripotent stem cells to study immune cells interactions with neurons. Front Mol Neurosci 14:767041. https:\/\/doi.org\/10.3389\/fnmol.2021.767041","journal-title":"Front Mol Neurosci"},{"key":"13190_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.clinbiochem.2018.07.003","volume":"59","author":"MA Icer","year":"2018","unstructured":"Icer MA, Gezmen-Karadag M (2018) The multiple functions and mechanisms of osteopontin. Clin Biochem 59:17\u201324. https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.07.003","journal-title":"Clin Biochem"},{"key":"13190_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/imr.13081","volume":"311","author":"A Yim","year":"2022","unstructured":"Yim A, Smith C, Brown AM (2022) Osteopontin\/secreted phosphoprotein-1 harnesses glial-, immune-, and neuronal cell ligand-receptor interactions to sense and regulate acute and chronic neuroinflammation. Immunol Rev 311:224\u2013233. https:\/\/doi.org\/10.1111\/imr.13081","journal-title":"Immunol Rev"},{"key":"13190_CR6","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1038\/s41598-021-83601-6","volume":"11","author":"YL Chai","year":"2021","unstructured":"Chai YL, Chong JR, Raquib AR et al (2021) Plasma osteopontin as a biomarker of Alzheimer\u2019s disease and vascular cognitive impairment. Sci Rep 11:4010. https:\/\/doi.org\/10.1038\/s41598-021-83601-6","journal-title":"Sci Rep"},{"key":"13190_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/biomedicines11010178","volume":"11","author":"M StampanoniBassi","year":"2023","unstructured":"StampanoniBassi M, Buttari F, Gilio L et al (2023) Osteopontin Is associated with multiple sclerosis relapses. Biomedicines 11:178. https:\/\/doi.org\/10.3390\/biomedicines11010178","journal-title":"Biomedicines"},{"key":"13190_CR8","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/acn3.52087","volume":"11","author":"W Ju","year":"2024","unstructured":"Ju W, Ban J-J, Im H-R et al (2024) Association of serum Spp1 levels with disease progression in ALS and SBMA. Ann Clin Transl Neurol 11:1809\u20131818. https:\/\/doi.org\/10.1002\/acn3.52087","journal-title":"Ann Clin Transl Neurol"},{"key":"13190_CR9","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/s41591-021-01295-9","volume":"27","author":"A M\u00e5nberg","year":"2021","unstructured":"M\u00e5nberg A, Skene N, Sanders F et al (2021) Altered perivascular fibroblast activity precedes ALS disease onset. Nat Med 27:640\u2013646. https:\/\/doi.org\/10.1038\/s41591-021-01295-9","journal-title":"Nat Med"},{"key":"13190_CR10","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","volume":"131","author":"JM Shefner","year":"2020","unstructured":"Shefner JM, Al-Chalabi A, Baker MR et al (2020) A proposal for new diagnostic criteria for ALS. Clin Neurophysiol 131:1975\u20131978. https:\/\/doi.org\/10.1016\/j.clinph.2020.04.005","journal-title":"Clin Neurophysiol"},{"key":"13190_CR11","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/brain\/awr351","volume":"135","author":"JC Roche","year":"2012","unstructured":"Roche JC, Rojas-Garcia R, Scott KM et al (2012) A proposed staging system for amyotrophic lateral sclerosis. Brain 135:847\u2013852. https:\/\/doi.org\/10.1093\/brain\/awr351","journal-title":"Brain"},{"key":"13190_CR12","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1111\/ene.15321","volume":"29","author":"YM Falzone","year":"2022","unstructured":"Falzone YM, Domi T, Mandelli A et al (2022) Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis. Eur J Neurol 29:1930\u20131939. https:\/\/doi.org\/10.1111\/ene.15321","journal-title":"Eur J Neurol"},{"key":"13190_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1212\/CPJ.0000000000000521","volume":"8","author":"E Dardiotis","year":"2018","unstructured":"Dardiotis E, Siokas V, Sokratous M et al (2018) Body mass index and survival from amyotrophic lateral sclerosis. Neurol Clin Pract 8:437\u2013444. https:\/\/doi.org\/10.1212\/CPJ.0000000000000521","journal-title":"Neurol Clin Pract"},{"key":"13190_CR14","doi-asserted-by":"publisher","first-page":"4045238","DOI":"10.1155\/2017\/4045238","volume":"2017","author":"C De Fusco","year":"2017","unstructured":"De Fusco C, Messina A, Monda V et al (2017) Osteopontin: relation between adipose tissue and bone homeostasis. Stem Cells Int 2017:4045238. https:\/\/doi.org\/10.1155\/2017\/4045238","journal-title":"Stem Cells Int"},{"key":"13190_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13024-023-00685-6","volume":"19","author":"KE Irwin","year":"2024","unstructured":"Irwin KE, Sheth U, Wong PC, Gendron TF (2024) Fluid biomarkers for amyotrophic lateral sclerosis: a review. Mol Neurodegener 19:9. https:\/\/doi.org\/10.1186\/s13024-023-00685-6","journal-title":"Mol Neurodegener"},{"key":"13190_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1395596","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Huang Z, Gao L et al (2024) Osteopontin\/SPP1: a potential mediator between immune cells and vascular calcification. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2024.1395596","journal-title":"Front Immunol"},{"key":"13190_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.immuni.2024.01.008","volume":"57","author":"Y Lan","year":"2024","unstructured":"Lan Y, Zhang X, Liu S et al (2024) Fate mapping of Spp1 expression reveals age-dependent plasticity of disease-associated microglia-like cells after brain injury. Immunity 57:349-363.e9. https:\/\/doi.org\/10.1016\/j.immuni.2024.01.008","journal-title":"Immunity"},{"key":"13190_CR18","doi-asserted-by":"publisher","first-page":"e2218915120","DOI":"10.1073\/pnas.2218915120","volume":"120","author":"Y Qiu","year":"2023","unstructured":"Qiu Y, Shen X, Ravid O et al (2023) Definition of the contribution of an Osteopontin-producing CD11c+ microglial subset to Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 120:e2218915120. https:\/\/doi.org\/10.1073\/pnas.2218915120","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13190_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41593-022-01205-3","volume":"26","author":"J Humphrey","year":"2023","unstructured":"Humphrey J, Venkatesh S, Hasan R et al (2023) Integrative transcriptomic analysis of the amyotrophic lateral sclerosis spinal cord implicates glial activation and suggests new risk genes. Nat Neurosci 26:150\u2013162. https:\/\/doi.org\/10.1038\/s41593-022-01205-3","journal-title":"Nat Neurosci"},{"key":"13190_CR20","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/jnnp-2018-319611","volume":"90","author":"C Moglia","year":"2019","unstructured":"Moglia C, Calvo A, Grassano M et al (2019) Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort. J Neurol Neurosurg Psychiatry 90:666\u2013673. https:\/\/doi.org\/10.1136\/jnnp-2018-319611","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13190_CR21","doi-asserted-by":"publisher","first-page":"12262","DOI":"10.1038\/s41598-019-48831-9","volume":"9","author":"Y Nakayama","year":"2019","unstructured":"Nakayama Y, Shimizu T, Matsuda C et al (2019) Body weight variation predicts disease progression after invasive ventilation in amyotrophic lateral sclerosis. Sci Rep 9:12262. https:\/\/doi.org\/10.1038\/s41598-019-48831-9","journal-title":"Sci Rep"},{"key":"13190_CR22","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/mus.27744","volume":"67","author":"SA Goutman","year":"2023","unstructured":"Goutman SA, Boss J, Iyer G et al (2023) Body mass index associates with amyotrophic lateral sclerosis survival and metabolomic profiles. Muscle Nerve 67:208\u2013216. https:\/\/doi.org\/10.1002\/mus.27744","journal-title":"Muscle Nerve"},{"key":"13190_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1080\/21678421.2022.2154678","volume":"24","author":"P Gebrehiwet","year":"2023","unstructured":"Gebrehiwet P, Meng L, Rudnicki SA et al (2023) MiToS and King\u2019s staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial. Amyotroph Lateral Scler Frontotemporal Degener 24:304\u2013310. https:\/\/doi.org\/10.1080\/21678421.2022.2154678","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"13190_CR24","doi-asserted-by":"publisher","first-page":"e200072","DOI":"10.1212\/NXI.0000000000200072","volume":"10","author":"N de Luna","year":"2023","unstructured":"de Luna N, Carbayo \u00c1, Dols-Icardo O et al (2023) Neuroinflammation-related proteins NOD2 and Spp1 are abnormally upregulated in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm 10:e200072. https:\/\/doi.org\/10.1212\/NXI.0000000000200072","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13190-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13190-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13190-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T06:26:15Z","timestamp":1752301575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13190-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["13190"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13190-1","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Tommaso Russo, Teuta Domi, Paride Schito, Yuri Matteo Falzone, Laura Pozzi, Massimo Locatelli, Nilo Riva, Edoardo G. Spinelli, and Angelo Quattrini have nothing to disclose. F. Agosta is an Associate Editor of NeuroImage: Clinical, has received speaker honoraria from Biogen Idec, Italfarmaco, Roche, Zambon and Eli Lilly, and receives or has received research supports from the Italian Ministry of Health, the Italian Ministry of University and Research, AriSLA (Fondazione Italiana di Ricerca per la SLA), the European Research Council, the EU Joint Programme \u2013 Neurodegenerative Disease Research (JPND), and Foundation Research on Alzheimer Disease (France). M. Filippi is Editor-in-Chief of the Journal of Neurology, Associate Editor of Human Brain Mapping, Neurological Sciences, and Radiology; received compensation for consulting services from Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi; speaking activities from Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA; participation in Advisory Boards for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda; scientific direction of educational events for Biogen, Merck, Roche, Celgene, Bristol-Myers Squibb, Lilly, Novartis, Sanofi-Genzyme; and receives research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Local ethical standards committee on human experimentation approved the study protocol, which has been performed in accordance with the ethical standards of the 1964 Declaration of Helsinki. Moreover, all participants provided written informed consent prior to study inclusion.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"452"}}